IDEX CORP (IEX)

US45167R1041 - Common Stock

212.38  +2.12 (+1.01%)

After market: 212.38 0 (0%)

Fundamental Rating

6

IEX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. IEX gets an excellent profitability rating and is at the same time showing great financial health properties. IEX is valied quite expensively at the moment, while it does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year IEX was profitable.
IEX had a positive operating cash flow in the past year.
Each year in the past 5 years IEX has been profitable.
Each year in the past 5 years IEX had a positive operating cash flow.

1.2 Ratios

IEX has a better Return On Assets (7.04%) than 69.23% of its industry peers.
With a decent Return On Equity value of 12.84%, IEX is doing good in the industry, outperforming 66.15% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.53%, IEX is doing good in the industry, outperforming 63.08% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IEX is in line with the industry average of 10.90%.
Industry RankSector Rank
ROA 7.04%
ROE 12.84%
ROIC 8.53%
ROA(3y)9.98%
ROA(5y)9.93%
ROE(3y)17.39%
ROE(5y)17.17%
ROIC(3y)11.6%
ROIC(5y)11.75%

1.3 Margins

IEX has a better Profit Margin (15.35%) than 90.77% of its industry peers.
IEX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 21.82%, IEX belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
In the last couple of years the Operating Margin of IEX has remained more or less at the same level.
IEX has a better Gross Margin (44.29%) than 83.85% of its industry peers.
IEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.82%
PM (TTM) 15.35%
GM 44.29%
OM growth 3Y0.42%
OM growth 5Y-0.41%
PM growth 3Y4.26%
PM growth 5Y1.95%
GM growth 3Y0.38%
GM growth 5Y-0.36%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IEX is creating some value.
The number of shares outstanding for IEX remains at a similar level compared to 1 year ago.
The number of shares outstanding for IEX has been reduced compared to 5 years ago.
Compared to 1 year ago, IEX has an improved debt to assets ratio.

2.2 Solvency

IEX has an Altman-Z score of 4.88. This indicates that IEX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.88, IEX is doing good in the industry, outperforming 73.85% of the companies in the same industry.
The Debt to FCF ratio of IEX is 3.32, which is a good value as it means it would take IEX, 3.32 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.32, IEX is doing good in the industry, outperforming 65.38% of the companies in the same industry.
A Debt/Equity ratio of 0.54 indicates that IEX is somewhat dependend on debt financing.
The Debt to Equity ratio of IEX (0.54) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.32
Altman-Z 4.88
ROIC/WACC0.96
WACC8.89%

2.3 Liquidity

A Current Ratio of 2.97 indicates that IEX has no problem at all paying its short term obligations.
IEX's Current ratio of 2.97 is fine compared to the rest of the industry. IEX outperforms 75.38% of its industry peers.
A Quick Ratio of 2.11 indicates that IEX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.11, IEX is doing good in the industry, outperforming 78.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.11

4

3. Growth

3.1 Past

The earnings per share for IEX have decreased by -8.69% in the last year.
Measured over the past years, IEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.73% on average per year.
Looking at the last year, IEX shows a decrease in Revenue. The Revenue has decreased by -3.06% in the last year.
IEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.68% yearly.
EPS 1Y (TTM)-8.69%
EPS 3Y16.49%
EPS 5Y8.73%
EPS Q2Q%-10.38%
Revenue 1Y (TTM)-3.06%
Revenue growth 3Y11.66%
Revenue growth 5Y5.68%
Sales Q2Q%0.6%

3.2 Future

The Earnings Per Share is expected to grow by 8.49% on average over the next years. This is quite good.
IEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.23% yearly.
EPS Next Y-3.22%
EPS Next 2Y2.62%
EPS Next 3Y4.46%
EPS Next 5Y8.49%
Revenue Next Year0.67%
Revenue Next 2Y4.12%
Revenue Next 3Y5.07%
Revenue Next 5Y7.23%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.69, the valuation of IEX can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of IEX indicates a slightly more expensive valuation: IEX is more expensive than 60.00% of the companies listed in the same industry.
IEX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 24.53, which indicates a rather expensive current valuation of IEX.
The rest of the industry has a similar Price/Forward Earnings ratio as IEX.
The average S&P500 Price/Forward Earnings ratio is at 22.83. IEX is around the same levels.
Industry RankSector Rank
PE 27.69
Fwd PE 24.53

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IEX indicates a slightly more expensive valuation: IEX is more expensive than 63.08% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.72
EV/EBITDA 20.34

4.3 Compensation for Growth

IEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.17
EPS Next 2Y2.62%
EPS Next 3Y4.46%

5

5. Dividend

5.1 Amount

IEX has a Yearly Dividend Yield of 1.31%.
IEX's Dividend Yield is a higher than the industry average which is at 1.69.
With a Dividend Yield of 1.31, IEX pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.31%

5.2 History

On average, the dividend of IEX grows each year by 8.58%, which is quite nice.
IEX has been paying a dividend for at least 10 years, so it has a reliable track record.
IEX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.58%
Div Incr Years15
Div Non Decr Years29

5.3 Sustainability

IEX pays out 41.07% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of IEX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP41.07%
EPS Next 2Y2.62%
EPS Next 3Y4.46%

IDEX CORP

NYSE:IEX (12/20/2024, 8:18:00 PM)

After market: 212.38 0 (0%)

212.38

+2.12 (+1.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners98.89%
Inst Owner Change0.41%
Ins Owners0.17%
Ins Owner Change0%
Market Cap16.08B
Analysts75.79
Price Target237.16 (11.67%)
Short Float %1.89%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield 1.31%
Dividend Growth(5Y)8.58%
DP41.07%
Div Incr Years15
Div Non Decr Years29
Ex-Date01-17 2025-01-17 (0.69)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.16%
Min EPS beat(2)-0.18%
Max EPS beat(2)-0.13%
EPS beat(4)2
Avg EPS beat(4)1.89%
Min EPS beat(4)-0.18%
Max EPS beat(4)5.89%
EPS beat(8)6
Avg EPS beat(8)3.03%
EPS beat(12)9
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)3.36%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.45%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-3.45%
Max Revenue beat(4)1.56%
Revenue beat(8)3
Avg Revenue beat(8)-0.06%
Revenue beat(12)6
Avg Revenue beat(12)0.88%
Revenue beat(16)9
Avg Revenue beat(16)0.81%
PT rev (1m)1.97%
PT rev (3m)3.14%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-6.99%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.6%
Valuation
Industry RankSector Rank
PE 27.69
Fwd PE 24.53
P/S 5.03
P/FCF 25.72
P/OCF 23.09
P/B 4.21
P/tB N/A
EV/EBITDA 20.34
EPS(TTM)7.67
EY3.61%
EPS(NY)8.66
Fwd EY4.08%
FCF(TTM)8.26
FCFY3.89%
OCF(TTM)9.2
OCFY4.33%
SpS42.19
BVpS50.43
TBVpS-11.18
PEG (NY)N/A
PEG (5Y)3.17
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 12.84%
ROCE 10.89%
ROIC 8.53%
ROICexc 9.46%
ROICexgc 49.44%
OM 21.82%
PM (TTM) 15.35%
GM 44.29%
FCFM 19.57%
ROA(3y)9.98%
ROA(5y)9.93%
ROE(3y)17.39%
ROE(5y)17.17%
ROIC(3y)11.6%
ROIC(5y)11.75%
ROICexc(3y)13.31%
ROICexc(5y)14.1%
ROICexgc(3y)62.26%
ROICexgc(5y)63.99%
ROCE(3y)14.81%
ROCE(5y)15.01%
ROICexcg growth 3Y-0.84%
ROICexcg growth 5Y-5.85%
ROICexc growth 3Y-4.45%
ROICexc growth 5Y-6.71%
OM growth 3Y0.42%
OM growth 5Y-0.41%
PM growth 3Y4.26%
PM growth 5Y1.95%
GM growth 3Y0.38%
GM growth 5Y-0.36%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.32
Debt/EBITDA 2.41
Cap/Depr 43.28%
Cap/Sales 2.23%
Interest Coverage 15.22
Cash Conversion 80.84%
Profit Quality 127.51%
Current Ratio 2.97
Quick Ratio 2.11
Altman-Z 4.88
F-Score4
WACC8.89%
ROIC/WACC0.96
Cap/Depr(3y)62.17%
Cap/Depr(5y)62.89%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.35%
Profit Quality(3y)99.38%
Profit Quality(5y)109.47%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.69%
EPS 3Y16.49%
EPS 5Y8.73%
EPS Q2Q%-10.38%
EPS Next Y-3.22%
EPS Next 2Y2.62%
EPS Next 3Y4.46%
EPS Next 5Y8.49%
Revenue 1Y (TTM)-3.06%
Revenue growth 3Y11.66%
Revenue growth 5Y5.68%
Sales Q2Q%0.6%
Revenue Next Year0.67%
Revenue Next 2Y4.12%
Revenue Next 3Y5.07%
Revenue Next 5Y7.23%
EBIT growth 1Y-8.72%
EBIT growth 3Y12.13%
EBIT growth 5Y5.25%
EBIT Next Year19.14%
EBIT Next 3Y13.14%
EBIT Next 5Y12.89%
FCF growth 1Y30.82%
FCF growth 3Y6.58%
FCF growth 5Y8.38%
OCF growth 1Y25.9%
OCF growth 3Y7.98%
OCF growth 5Y8.38%